ReviewJPRAS open2026
Systematic review of buried flap reconstructions after nipple-sparing mastectomy.
Review in JPRAS open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Although autologous reconstruction after nipple-sparing mastectomy (NSM) is well established, the subset of buried-free flap reconstructions remains less well characterised. With evolving surgical techniques understanding the safety, efficacy, and outcomes of buried-free flap reconstructions is increasingly important. Aim: To review recent literature regarding autologous buried-free flap reconstructions post mastectomy, including demographics, indications, outcomes and complications. Methods: A search of PubMed and Medline databases was performed using the keywords "deep inferior epigastric perforator flap", "DIEP", "deep inferior epigastric flap", "free flap", "transverse upper gracilis", "TUG", "bury", "buried", "burying", "autologous breast reconstruction", "autologous reconstruction", "breast reconstruction", and "nipple-sparing mastectomy" using a 3-component search along with the Boolean operators 'AND' and 'OR'. Results: Seventy-five studies were retrieved with 12 meeting the inclusion criteria. Four studies directly compared buried and non-buried flaps. A total of 385 patients underwent 585 buried-free flap reconstructions. These were predominantly DIEP (70.8%), immediate (76.8%) and post-NSM (72.6%). Flap loss was similar (1.5%vs 1.8%; partial 0.3% vs 0.9%). Return-to-theatre rates were 7.5% for buried and 9.1% for non-buried flaps. Anastomotic complications were similar (2.8%vs 2.6%). Buried flaps demonstrated higher rates of fat necrosis (4.1%vs 2.1%) and infection (4.5%vs 1.5%), while non-buried flaps had higher wound dehiscence rates (5.9%vs 4.6%). Revision procedures were more common in buried flaps (59.9%vs 49.2%). Conclusions: Buried-free flap reconstruction following NSM is safe and technically feasible, with comparable complication rates compared to conventional techniques. Standardised monitoring and patient-reported outcomes are needed to optimise selection and wider adoption.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.